0% to 200% of the target award. The fair value of the performance-based RSUs granted is recorded as compensation
expense over the performance period and will vest 2/3rds on December 31, 2024, and 1/3rd on December 31, 2025, with
an offsetting increase in stockholders’ equity. Any awards earned on December 31, 2024 based on achievement of the
applicable performance metrics but vesting on December 31, 2025 will convert into RSAs that are eligible to vest on
December 31, 2025 based on the key employee’s continued employment or service through that date. Dividend
equivalents are accrued by the Company during the performance period and paid to the holder if and when the
performance-based RSUs vest. Following the conclusion of the performance period on December 31, 2024, the Board
determined that the cost savings, product origination volumes and incremental liquidity generation goals were achieved
at maximum payout and the distributable ROE goal was not achieved. As such, on February 3, 2025, the Board approved
the settlement of 333,828 performance-based RSUs. The fair value of the performance-based RSUs granted was
recorded as compensation expense over the performance period with an offsetting increase in stockholders’ equity.
In February 2023, the Company granted, to certain key employees, 92,451 performance-based RSUs at a grant date fair
value of $12.98 per performance-based RSU. The performance-based RSUs are allocated 50% to awards that may be
earned based on achievement of performance goals related to distributable ROE for the three-year forward-looking
period ending December 31, 2025 and 50% to awards that may be earned based on achievement of performance goals
related to relative TSR for such three-year forward-looking performance period relative to the performance of a
designated peer group. Subject to the distributable ROE metric and relative TSR achieved during the performance
period, the actual number of shares that the key employees receive at the end of the performance period may range from
0% to 200% of the target award. The fair value of the performance-based RSUs is recorded as compensation expense
over the performance period and will cliff vest at the end of the three-year performance period, with an offsetting
increase in stockholders’ equity. Dividend equivalents are accrued by the Company during the performance period and
paid to the holder if and when the performance-based RSUs vest.
2022 performance-based RSUs. In February 2022, the Company granted, to certain key employees, 84,566
performance-based RSUs at a grant date fair value of $14.19 per performance-based RSU. During April 2024, 8,809
performance-based RSUs were forfeited. The performance-based RSUs are allocated 50% to awards that may be earned
based on achievement of performance goals related to distributable ROE for the three-year forward-looking period
ending December 31, 2024 and 50% to awards that may be earned based on achievement of performance goals related to
relative TSR for such three-year forward-looking performance period relative to the performance of a designated peer
group. Subject to the distributable ROE metric and relative TSR achieved during the vesting period, the actual number of
shares that the key employees receive at the end of the performance period may range from 0% to 200% of the target
award. The fair value of the performance-based RSUs is recorded as compensation expense over the performance period
and will cliff vest at the end of a three-year performance period, with an offsetting increase in stockholders’ equity.
Dividend equivalents are accrued by the Company during the performance period and paid to the holder if and when the
performance-based RSUs vest. Following the conclusion of the performance period on December 31, 2024, the Board
determined that the distributable ROE threshold goal was achieved and the relative TSR threshold goal was achieved. As
such, on February 22, 2025, the Board approved the settlement of 57,029 performance-based RSUs. The fair value of the
performance-based RSUs granted was recorded as compensation expense over the performance period with an offsetting
increase in stockholders’ equity.
2021 performance-based RSUs. In February 2021, the Company granted, to certain key employees, 61,895
performance-based RSUs at a grant date fair value of $12.82 per performance-based RSU. During October 2021, 18,568
performance-based RSUs were forfeited. The performance-based RSUs are allocated 50% to awards that may be earned
based on achievement of performance goals related to absolute TSR for the three-year forward-looking period ending
December 31, 2023 and 50% to awards that may be earned based on achievement of performance goals related to TSR
for such three-year forward-looking performance period relative to the performance of a designated peer group. Subject
to the absolute and relative TSR achieved during the performance period, the actual number of shares that the key
employees receive at the end of the performance period may range from 0% to 300% of the target award. Dividend
equivalents are accrued by the Company during the performance period and paid to the holder if and when the
performance-based RSUs vest. Following the conclusion of the performance period on December 31, 2023, the Board
determined that the relative TSR target goal was achieved and the absolute TSR goal was not achieved. As such, on
January 9, 2024, the Board approved the settlement of 29,215 performance-based RSUs. The fair value of the
performance-based RSUs granted was recorded as compensation expense over the performance period with an offsetting
increase in stockholders’ equity.
Preferred Stock